China Digest: Bamboocloud bags $44m; Lilly Asia leads $25m funding in ImmuneOnco

Bamboocloud has garnered 300 million yuan ($44 million) in a Series C round of financing from Sequoia Capital China and Kunlun Fund, while ImmuneOnco Biopharma has secured $25 million in a Series B round led by Lilly Asia Ventures.

Bamboocloud bags $44m Series C round

Chinese identity and access management (IAM) platform Bamboocloud has garnered 300 million yuan ($44 million) in a Series C round of financing from Sequoia Capital China and Kunlun Fund, a Beijing-based private equity firm focused on TMT (technology, media, telecom) and new consumption, Bamboocloud posted on WeChat on Monday.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter